Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Biersack

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Non-Coding RNA Research|August 31, 2018
Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and preventionBernhard Biersack
Non-Coding RNA Research|August 31, 2018
Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitaminsBernhard Biersack
Non-Coding RNA Research|August 31, 2018
Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAsBernhard Biersack
Non-Coding RNA Research|February 28, 2019
Relations between approved platinum drugs and non-coding RNAs in mesotheliomaBernhard Biersack
Non-Coding RNA Research|February 28, 2019
Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesotheliomaBernhard Biersack
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Alkylating anticancer agents and their relations to microRNAsBernhard Biersack
International Journal of Molecular Sciences|May 13, 2023
Editorial for the Special Issue-"Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies"Bernhard Biersack
International Journal of Molecular Sciences|June 19, 2024
The Antifungal Potential of Niclosamide and Structurally Related SalicylanilidesBernhard Biersack
International Journal of Molecular Sciences|March 13, 2025
Special Issue "Antifungal Drug Discovery: Progresses, Challenges, Opportunities"Bernhard Biersack
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
3,3'-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAsBernhard Biersack
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Non-Coding RNA Research|August 31, 2018
Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and preventionBernhard Biersack
Non-Coding RNA Research|August 31, 2018
Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitaminsBernhard Biersack
Non-Coding RNA Research|August 31, 2018
Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAsBernhard Biersack
Non-Coding RNA Research|February 28, 2019
Relations between approved platinum drugs and non-coding RNAs in mesotheliomaBernhard Biersack
Non-Coding RNA Research|February 28, 2019
Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesotheliomaBernhard Biersack
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Alkylating anticancer agents and their relations to microRNAsBernhard Biersack
International Journal of Molecular Sciences|May 13, 2023
Editorial for the Special Issue-"Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies"Bernhard Biersack
International Journal of Molecular Sciences|June 19, 2024
The Antifungal Potential of Niclosamide and Structurally Related SalicylanilidesBernhard Biersack
International Journal of Molecular Sciences|March 13, 2025
Special Issue "Antifungal Drug Discovery: Progresses, Challenges, Opportunities"Bernhard Biersack
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
3,3'-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAsBernhard Biersack
Pageof 14